Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, L3 5QA, UK.
Centre for Drug and Diagnostics, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, L3 5QA, UK.
Microb Genom. 2022 Apr;8(4). doi: 10.1099/mgen.0.000789.
Resistance to piperacillin/tazobactam (TZP) in has predominantly been associated with mechanisms that confer resistance to third-generation cephalosporins. Recent reports have identified strains with phenotypic resistance to piperacillin/tazobactam but susceptibility to third-generation cephalosporins (TZP-R/3GC-S). In this study we sought to determine the genetic diversity of this phenotype in (=58) isolated between 2014-2017 at a single tertiary hospital in Liverpool, UK, as well as the associated resistance mechanisms. We compare our findings to a UK-wide collection of invasive isolates (=1509) with publicly available phenotypic and genotypic data. These data sets included the TZP-R/3GC-S phenotype (=68), and piperacillin/tazobactam and third-generation cephalosporin-susceptible (TZP-S/3GC-S, =1271) phenotypes. The TZP-R/3GC-S phenotype was displayed in a broad range of sequence types, which was mirrored in the same phenotype from the UK-wide collection, and the overall diversity of invasive isolates. The TZP-R/3GC-S isolates contained a diverse range of plasmids, indicating multiple acquisition events of TZP resistance mechanisms rather than clonal expansion of a particular plasmid or sequence type. The putative resistance mechanisms were equally diverse, including hyperproduction of TEM-1, either via strong promoters or gene amplification, carriage of inhibitor-resistant β-lactamases, and an S133G mutation detected for the first time in clinical isolates. Several of these mechanisms were present at a lower abundance in the TZP-S/3GC-S isolates from the UK-wide collection, but without the associated phenotypic resistance to TZP. Eleven (19%) of the isolates had no putative mechanism identified from the genomic data. Our findings highlight the complexity of this cryptic phenotype and the need for continued phenotypic monitoring, as well as further investigation to improve detection and prediction of the TZP-R/3GC-S phenotype from genomic data.
对哌拉西林/他唑巴坦(TZP)的耐药性主要与赋予对第三代头孢菌素耐药性的机制有关。最近的报告已经确定了具有对哌拉西林/他唑巴坦表型耐药性但对第三代头孢菌素(TZP-R/3GC-S)敏感的 菌株。在这项研究中,我们试图确定在英国利物浦的一家三级医院 2014 年至 2017 年间分离的 58 株 菌株的这种表型的遗传多样性,以及相关的耐药机制。我们将我们的发现与英国全国范围内的侵袭性 菌株的集合进行了比较(= 1509),这些菌株具有公开的表型和基因型数据。这些数据集包括 TZP-R/3GC-S 表型(= 68)和哌拉西林/他唑巴坦和第三代头孢菌素敏感(TZP-S/3GC-S,= 1271)表型。TZP-R/3GC-S 表型在广泛的序列类型中显示,这与英国全国范围内的相同表型以及侵袭性 菌株的总体多样性相吻合。TZP-R/3GC-S 分离株含有多种质粒,表明 TZP 耐药机制的多次获得事件,而不是特定质粒或序列类型的克隆扩增。推测的耐药机制同样多样化,包括 TEM-1 的超产量,通过强启动子或基因扩增,携带抑制剂耐药的β-内酰胺酶,以及首次在临床分离株中检测到的 S133G 突变。这些机制中的一些在英国全国范围内的 TZP-S/3GC-S 分离株中存在较低的丰度,但没有与 TZP 耐药相关的表型。从基因组数据中鉴定出的 11 株(19%)分离株没有推测的机制。我们的发现强调了这种隐匿表型的复杂性,需要持续进行表型监测,以及进一步研究以提高从基因组数据中检测和预测 TZP-R/3GC-S 表型的能力。